Skip to main content

CNO Financial Group, Inc.

corporate_fare Company Profile

CNO Financial Group, Inc.

CNO·NYSE·Finance·CIK 0001224608

CNO Financial Group, Inc. (CNO) is a holding company for insurance companies that develop, market, and administer health insurance, annuity, individual life insurance, and other insurance and financial services products. CNO focuses on serving middle-income pre-retiree and retired Americans. The company sells its products through exclusive agents, independent producers (some of whom sell one or more product lines exclusively), and direct marketing. As of December 31, 2025, CNO had total assets of $38.8 billion and shareholders' equity of $2.6 billion, which included an accumulated other comprehensive loss of $1.1 billion. For the year ended December 31, 2025, CNO had revenues of $4.5 billion and net income of $229.3 million. CNO views its operations through three insurance product lines: annuity, health, and life, along with investment and fee income segments. These segments are aligned based on common characteristics, comparability of profit margins, and how the Chief Executive Officer makes operating decisions and assesses performance. CNO markets its products through the Consumer and Worksite Divisions, which reflect the customers served. The Consumer and Worksite Divisions primarily focus on marketing insurance products, with several types sold in both divisions and underwritten similarly. The Consumer Division serves individual consumers through phone, virtual, online, face-to-face agent interactions, or a combination of sales channels. This structure unifies consumer capabilities into a single division, integrating agent sales forces with a direct-to-consumer insurance business experienced in advertising, web/digital, and call center support.

CNO Financial Group, Inc. (NYSE:CNO) is a publicly traded company in the Finance sector. Wiseek has independently scored 10 items for CNO at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-10-31, rated 7/10. Across its 10 most recent items scored 7 or higher, the top rating is 8/10, with 6 rated 8 or above. Recent SEC coverage for CNO spans 8-K, 10-Q, DEF 14A, 10-K.

Recent high-impact activity:

  • CNO Cuts 2026 Expense Ratio Guidance, Returns $77M as Medicare Supplement Sales Jump 41%
  • CNO Beats on 47% Operating EPS Growth, Raises 2026 Guidance 9% at Midpoint
  • CNO Financial Posts $1.09B in Third-Quarter Revenue
  • CNO Financial Raises 2026 EPS Outlook After 45% Q2 Surge
  • CNO Financial Lifts Full-Year Operating EPS View by 8% After a 45% Q2 Surge

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$4.49B
Net Income
$229.3M
Diluted EPS
$2.30
Op. Cash Flow
$675.7M
Operating Income
$553.2M
Cash & Equivalents
$983.5M
Debt / Equity
0.00×
Net Margin
5.1%
Shares Outstanding
94.48M sh
Source: 10-K · filed 2026-02-24 · accession 0001224608-26-000017

Short Interest & Short Volume

2.73 days to cover

FINRA reported short interest of 2,565,316 shares in CNO as of the October 30, 2026 settlement, a 6.0% decrease from the prior period — about 2.7 days to cover at its recent average daily volume. On November 20, 2026, 61.1% of CNO volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)2,565,316 shares as of October 30, 2026
Change vs prior period▼ 6.0%
Days to cover2.73 at avg daily volume of 939,867
Daily short volume (FINRA facilities)61.1% of 107,924 shares on November 20, 2026
5-day average short volume55.9%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with C →
$53.96
52-week range · as of 2026-10-29 $38.99 – $57.59
Market cap
$4.93B
Volume
680.2K (0.8× avg)
3-mo avg 827K
Live data · 2026-11-21 17:13 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed CNO - Latest Insights

CNO
Oct 31, 2026, 3:00 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $57.67
Real-time Price: $53.96 info
Change: -$3.71 (-6%) info
Market Cap: $4.929B info
CNO
Oct 29, 2026, 4:20 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $55.75
Real-time Price: $53.96 info
Change: -$1.79 (-3%) info
Market Cap: $4.929B info
CNO
Oct 29, 2026, 4:15 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $55.17
Real-time Price: $53.96 info
Change: -$1.21 (-2%) info
Market Cap: $4.929B info
CNO
Jul 30, 2026, 4:25 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $56.00
Real-time Price: $53.96 info
Change: -$2.04 (-4%) info
Market Cap: $4.929B info
CNO
Jul 30, 2026, 4:16 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $56.00
Real-time Price: $53.96 info
Change: -$2.04 (-4%) info
Market Cap: $4.929B info
CNO
May 07, 2026, 4:21 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $45.89
Real-time Price: $53.96 info
Change: +$8.07 (+18%) info
Market Cap: $4.929B info
CNO
Apr 30, 2026, 4:29 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $44.45
Real-time Price: $53.96 info
Change: +$9.51 (+21%) info
Market Cap: $4.929B info
CNO
Mar 26, 2026, 4:13 PM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $40.96
Real-time Price: $53.96 info
Change: +$13.00 (+32%) info
Market Cap: $4.929B info
CNO
Feb 24, 2026, 4:54 PM EST
Filing Type: 10-K
Importance Score:
7
Price at Filing: $41.62
Real-time Price: $53.96 info
Change: +$12.34 (+30%) info
Market Cap: $4.929B info
CNO
Feb 05, 2026, 4:16 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $42.31
Real-time Price: $53.96 info
Change: +$11.65 (+28%) info
Market Cap: $4.929B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets